Living donor kidney transplantation is an effective option of renal replacement therapy in patients with light-chain amyloidosis (AL)

Ann Hematol. 2020 Dec;99(12):2961-2962. doi: 10.1007/s00277-020-04230-z. Epub 2020 Aug 29.

¹ Department of Nephrology and Renal Transplantation, Centro de Referencia en Enfermedad Glomerular Compleja del Sistema Nacional de Salud (CSUR), Hospital Clinic-Universitat de Barcelona, Barcelona, Spain. eguillen@clinic.cat.
² Department of Nephrology and Renal Transplantation, Centro de Referencia en Enfermedad Glomerular Compleja del Sistema Nacional de Salud (CSUR), Hospital Clinic-Universitat de Barcelona, Barcelona, Spain.
³ Department of Internal Medicine, Hospital Angeles-Clinica Londres, Mexico City, Mexico.
⁴ Department of Hematology, Amyloidosis and Myeloma Unit, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
⁵ Department of Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

No abstract available

Publication types